A review of pivotal clinical trials for semaglutide (STEP, SUSTAIN), dulaglutide (REWIND), liraglutide (LEADER), and tirzepatide (SURPASS, SURMOUNT) does not identify muscle cramps as occurring at significantly higher rates compared to placebo groups
doi: 10.1007/s00125-011-2340-0 144 SergiDNaumovskiNHeilbronnLKAbeywardenaMOCallaghanNLionettiLet al
IGF-1 LR3 is widely used in vitro to explore cell growth, survival, and differentiation , particularly in skeletal muscle, fibroblast, and neuronal models
Combined with Sermorelin's hypothesized potential to modulate growth hormone levels, the blend might provide insights into the mechanisms underlying tissue regeneration and strength
We investigated how GLP-1RAs impact weight changes in patients who underwent bariatric surgery compared to a placebo arm